nach oben

Erschienen in:

22.03.2016 | Original Article

A collaborative care program for management of common mental disorders among diabetic patients in a primary healthcare setting

verfasst von: Zeinab Moinfar, Mojtaba Sedaghat, Farid Abolhassani, Vandad Sharifi, Zahra Moinfar, Sahar Eftekhari, Farzaneh Mirzaaghaee

Erschienen in: Journal of Public Health | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

Aims

Type 2 diabetes mellitus (T2DM) is a chronic condition with high and increasing prevalence. Psychiatric disorders are very common among these patients. We aimed to assess the effect of a collaborative care program for management of common mental disorders among T2DM patients on their metabolic outcomes.

Subjects and methods

In this before-after study, a group of T2DM patients was enrolled from nine chronic care centers of a primary healthcare service. A trained team managed both the psychiatric and metabolic conditions according to evidence-based guidelines. The primary care team was in collaborative contact with a specialized service at a Community Mental Health Center. Patients’ glycemic measures, lipid profile, and weight were measured 3 months after the psychiatric intervention.

Results

Among 2757 diabetic patients visited, 536 (19.44 %) were diagnosed as having a common mental disorder. Mean age of included patients (435) was 56.5 ± 9.74. Major depressive disorder and generalized anxiety disorder were the most common mental disorders with a frequency of 219 (50.3 %) and 197 (46.7 %), respectively. There was no statistically significant improvement in glycemic and metabolic control after the psychiatric intervention; however, control of blood pressure was improved. Moreover, significant improvements were observed in average glycosylated hemoglobin (HbA1c) (p < 0.001) and fasting plasma glucose (FPG) (p < 0.01) in patients with previously poor glycemic control.

Conclusion

Although management of psychiatric conditions in a collaborative care program yielded no significant effect on metabolic outcomes and glycemic control in the total sample, patients with poor glycemic control experienced significant improvement in FPG and HbA_1c levels.

American Diabetes Association (2007) Standards of medical care in diabetes-2007. Diabetes Care 30(Suppl 1):S4–S41. doi:10.2337/dc07-S004 CrossRef

American Psychiatric Asociation (2000) Diagnostic and Statistical Manual of Mental Disorders. 4th text revision ed. American Psychiatric Association, Washington, pp 553–557

Atlantis E, Browning C, Sims J, Kendig H (2010) Diabetes incidence associated with depression and antidepressants in the Melbourne Longitudinal Studies on Healthy Ageing (MELSHA). Int J Geriatr Psychiatry 25:688–696. doi:10.1002/gps.2409 CrossRefPubMed

Chaudhry R, Mishra P, Mishra J, Parminder S, Mishra BP (2010) Psychiatric morbidity among diabetic patients: a hospital-based study. Ind Psychiatry J 19:47–49. doi:10.4103/0972-6748.77637 CrossRefPubMedPubMedCentral

Coventry PA, Hays R, Dickens C, Bundy C, Garrett C, Cherrington A, Chew-Graham C (2011) Talking about depression: a qualitative study of barriers to managing depression in people with long term conditions in primary care. BMC Fam Pract 12:10. doi:10.1186/1471-2296-12-10 CrossRefPubMedPubMedCentral

de Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ (2001) Association of depression and diabetes complications: a meta-analysis. Psychosom Med 63:619–630CrossRefPubMed

Deuschle M (2013) Effects of antidepressants on glucose metabolism and diabetes mellitus type 2 in adults. Curr Opin Psychiatry 26:60–65. doi:10.1097/YCO.0b013e32835a4206 CrossRefPubMed

Esteghamati A, Etemad K, Koohpayehzadeh J, Abbasi M, Meysamie A, Noshad S, Nakhjavani M (2014) Trends in the prevalence of diabetes and impaired fasting glucose in association with obesity in Iran: 2005–2011. Diabetes Res Clin Pract 103:319–327. doi:10.1016/j.diabres.2013.12.034 CrossRefPubMed

Gehlawat P, Gupta R, Rajput R, Gahlan D, Gehlawat VK (2013) Diabetes with comorbid depression: role of SSRI in better glycemic control. Asian J Psychiatr 6:364–368. doi:10.1016/j.ajp.2013.03.007 CrossRefPubMed

Gonzalez JS, Peyrot M, McCarl LA, Collins EM, Serpa L, Mimiaga MJ, Safren SA (2008) Depression and diabetes treatment nonadherence: a meta-analysis. Diabetes Care 31:2398–2403. doi:10.2337/dc08-1341 CrossRefPubMedPubMedCentral

Huang Y, Wei X, Wu T, Chen R, Guo A (2013) Collaborative care for patients with depression and diabetes mellitus: a systematic review and meta-analysis. BMC Psychiatry 13:260. doi:10.1186/1471-244x-13-260 CrossRefPubMedPubMedCentral

International Diabetes Federation (2011) IDF diabetes atlas, 5 ed. Brussels, Belgium: International Diabetes Federation. http://www.idf.org/diabetesatlas

Kinder LS, Kamarck TW, Baum A, Orchard TJ (2002) Depressive symptomatology and coronary heart disease in type I diabetes mellitus: a study of possible mechanisms. Health Psychol 21:542–552CrossRefPubMed

Krishnan KR (2005) Treatment of depression in the medically ill. J Clin Psychopharmacol 25:S14–S18CrossRefPubMed

Li C, Ford ES, Zhao G, Ahluwalia IB, Pearson WS, Mokdad AH (2009) Prevalence and correlates of undiagnosed depression among US adults with diabetes: the Behavioral Risk Factor Surveillance System, 2006. Diabetes Res Clin Pract 83:268–279. doi:10.1016/j.diabres.2008.11.006 CrossRefPubMed

Lloyd CE, Pambianco G, Orchard TJ (2010) Does diabetes-related distress explain the presence of depressive symptoms and/or poor self-care in individuals with type 1 diabetes? Diabet Med 27:234–237. doi:10.1111/j.1464-5491.2009.02896.x CrossRefPubMedPubMedCentral

Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Memish ZA (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study. Lancet 380:2095–2128. doi:10.1016/s0140-6736(12)61728-0 CrossRefPubMed

Lustman PJ, Anderson RJ, Freedland KE, de Groot M, Carney RM, Clouse RE (2000) Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care 23:934–942CrossRefPubMed

Lustman PJ, Clouse RE, Carney RM (1988) Depression and the reporting of diabetes symptoms. Int J Psychiatry Med 18:295–303CrossRefPubMed

Maia AC, Braga Ade A, Brouwers A, Nardi AE, Oliveira e Silva A (2012) Prevalence of psychiatric disorders in patients with diabetes types 1 and 2. Compr Psychiatry 53:1169–1173. doi:10.1016/j.comppsych.2012.03.011 CrossRefPubMed

Markowitz SM, Gonzalez JS, Wilkinson JL, Safren SA (2011) A review of treating depression in diabetes: emerging findings. Psychosomatics 52:1–18. doi:10.1016/j.psym.2010.11.007 CrossRefPubMedPubMedCentral

Mendenhall E, Norris SA, Shidhaye R, Prabhakaran D (2014) Depression and type 2 diabetes in low- and middle-income countries: a systematic review. Diabetes Res Clin Pract 103:276–285. doi:10.1016/j.diabres.2014.01.001 CrossRefPubMedPubMedCentral

Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, Memish ZA (2012) Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study. Lancet 380:2197–2223. doi:10.1016/s0140-6736(12)61689-4 CrossRefPubMed

Musselman DL, Ziemer DC, McNutt MD, Seay JS, Royster EB, Larsen B, Harvey PD (2014) Depression, deficits in functional capacity, and impaired glycemic control in urban African Americans with type 2 diabetes. J Psychiatr Res 52:21–27. doi:10.1016/j.jpsychires.2014.01.006 CrossRefPubMed

Nuyen J, Spreeuwenberg PM, Van Dijk L, den Bos GA, Groenewegen PP, Schellevis FG (2008) The influence of specific chronic somatic conditions on the care for co-morbid depression in general practice. Psychol Med 38:265–277. doi:10.1017/s0033291707001298 CrossRefPubMed

O’Connor PJ, Crain AL, Rush WA, Hanson AM, Fischer LR, Kluznik JC (2009) Does diabetes double the risk of depression? Ann Fam Med 7:328–335. doi:10.1370/afm.964 CrossRefPubMedPubMedCentral

O’Kane M, Wiles PG, Wales JK (1994) Fluoxetine in the treatment of obese type 2 diabetic patients. Diabet Med 11:105–110CrossRefPubMed

Paile-Hyvarinen M, Wahlbeck K, Eriksson JG (2003) Quality of life and metabolic status in mildly depressed women with type 2 diabetes treated with paroxetine: a single-blind randomised placebo controlled trial. BMC Fam Pract 4:7. doi:10.1186/1471-2296-4-7 CrossRefPubMedPubMedCentral

Park H, Hong Y, Lee H, Ha E, Sung Y (2004) Individuals with type 2 diabetes and depressive symptoms exhibited lower adherence with self-care. J Clin Epidemiol 57:978–984. doi:10.1016/j.jclinepi.2004.01.015 CrossRefPubMed

Pijl H, Koppeschaar HP, Willekens FL, Op de Kamp I, Veldhuis HD, Meinders AE (1991) Effect of serotonin re-uptake inhibition by fluoxetine on body weight and spontaneous food choice in obesity. Int J Obes 15:237–242PubMed

Renn BN, Feliciano L, Segal DL (2011) The bidirectional relationship of depression and diabetes: a systematic review. Clin Psychol Rev 31:1239–1246. doi:10.1016/j.cpr.2011.08.001 CrossRefPubMed

Rotella F, Mannucci E (2013) Diabetes mellitus as a risk factor for depression. A meta-analysis of longitudinal studies. Diabetes Res Clin Pract 99:98–104. doi:10.1016/j.diabres.2012.11.022 CrossRefPubMed

Roy MS, Roy A, Affouf M (2007) Depression is a risk factor for poor glycemic control and retinopathy in African-Americans with type 1 diabetes. Psychosom Med 69:537–542. doi:10.1097/PSY.0b013e3180df84e2 CrossRefPubMed

Serretti A, Mandelli L (2010) Antidepressants and body weight: a comprehensive review and meta-analysis. J Clin Psychiatry 71:1259–1272. doi:10.4088/JCP.09r05346blu CrossRefPubMed

Sharifi V, Abolhasani F, Farhoudian A, Amin-Esmaeili M (2014) Community mental health centers in Iran: planning evidence-based services. Iranian J Psychiatr Clin Psychol 19:163–176

Shehatah A, Rabie MA, Al-Shahry A (2010) Prevalence and correlates of depressive disorders in elderly with type 2 diabetes in primary health care settings. J Affect Disord 123:197–201. doi:10.1016/j.jad.2009.09.002 CrossRefPubMed

Smith KJ, Beland M, Clyde M, Gariepy G, Page V, Badawi G, Schmitz N (2013) Association of diabetes with anxiety: a systematic review and meta-analysis. J Psychosom Res 74:89–99. doi:10.1016/j.jpsychores.2012.11.013 CrossRefPubMed

Tellez-Zenteno JF, Cardiel MH (2002) Risk factors associated with depression in patients with type 2 diabetes mellitus. Arch Med Res 33:53–60CrossRefPubMed

Teo SK, Ee CH (1997) Hypoglycaemia in the elderly. Singap Med J 38:432–434

Von Korff M, Katon W, Lin EH, Simon G, Ciechanowski P, Ludman E, Young B (2005) Work disability among individuals with diabetes. Diabetes Care 28:1326–1332CrossRef

Wang MY, Tsai PS, Chou KR, Chen CM (2008) A systematic review of the efficacy of non-pharmacological treatments for depression on glycaemic control in type 2 diabetics. J Clin Nurs 17:2524–2530. doi:10.1111/j.1365-2702.2008.02301.x CrossRefPubMed

Wilkins TL, Sambamoorthi U (2011) Antidepressant use, depression, lifestyle factors, and new-onset diabetes. Int Clin Psychopharmacol 26:159–168. doi:10.1097/YIC.0b013e328342ce31 CrossRefPubMed

Ye Z, Chen L, Yang Z, Li Q, Huang Y, He M, Hu R (2011) Metabolic effects of fluoxetine in adults with type 2 diabetes mellitus: a meta-analysis of randomized placebo-controlled trials. PLoS One 6:e21551. doi:10.1371/journal.pone.0021551 CrossRefPubMedPubMedCentral

Zhang X, Norris SL, Chowdhury FM, Gregg EW, Zhang P (2007) The effects of interventions on health-related quality of life among persons with diabetes: a systematic review. Med Care 45:820–834. doi:10.1097/MLR.0b013e3180618b55 CrossRefPubMed

Zhang X, Norris SL, Gregg EW, Cheng YJ, Beckles G, Kahn HS (2005) Depressive symptoms and mortality among persons with and without diabetes. Am J Epidemiol 161:652–660. doi:10.1093/aje/kwi089 CrossRefPubMed

Titel: A collaborative care program for management of common mental disorders among diabetic patients in a primary healthcare setting
verfasst von: Zeinab Moinfar
Mojtaba Sedaghat
Farid Abolhassani
Vandad Sharifi
Zahra Moinfar
Sahar Eftekhari
Farzaneh Mirzaaghaee
Publikationsdatum: 22.03.2016
Verlag: Springer Berlin Heidelberg
Erschienen in: Journal of Public Health / Ausgabe 4/2016
Print ISSN: 2198-1833
Elektronische ISSN: 1613-2238
DOI: https://doi.org/10.1007/s10389-016-0722-y

Springer Medizin

Abstract

Aims

Subjects and methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2016

Is there evidence for better health care for cancer patients in certified centers? A systematic review

Self-efficacy, self-care behaviours and glycaemic control in type 2 diabetic patients in Riyadh, Saudi Arabia

Anemia in pregnancy: Factors influencing knowledge and attitudes among mothers in southeastern Nigeria

Erratum to: Building capacity to reduce health inequalities through health promotion in Europe

Impact of acculturation and its factors on metabolic syndrome in South Asian American adults from two community health centers

Lifestyle health risk factors and multiple non-communicable diseases among the adult population in India: a cross-sectional study